A Pilot Study on Hyperthermic Intraperitoneal Chemotherapy after Radical or Partial Cystectomy with Pelvic Lymph Node Dissection for High-risk Muscle-invasive Bladder Cancer
Eur Urol. 2023 Dec;84(6):604-606.
doi: 10.1016/j.eururo.2023.06.005.
Epub 2023 Jun 21.
1 Department of Urology, Weill Cornell Medicine/New York-Presbyterian, New York, NY, USA.
2 Department of Medicine, Division of Hematology & Medical Oncology, Weill Cornell Medicine/New York-Presbyterian, New York, NY, USA; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA; Department of Cell and Developmental Biology, Weill Cornell Medicine, New York, NY, USA.
3 Department of Medicine, Division of Hematology & Medical Oncology, Weill Cornell Medicine/New York-Presbyterian, New York, NY, USA.
4 Division of Urology, Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey and Robert Wood Johnson University Hospital, New Brunswick, NJ, USA.
5 Department of Urology, University of Florida Health, Gainesville, FL, USA.
6 Department of Urology, Weill Cornell Medicine/New York-Presbyterian, New York, NY, USA. Electronic address: dss2001@med.cornell.edu.